next message in archive
no next message in thread
previous message in archive
Index of Subjects
----13230657194010274554 Content-Type: text/plain; Content-Transfer-Encoding: quoted-printable Stock Finder Newsletter wants to inform aggressive investors of a company = that we feel is extremely undervalued and poised for growth. 12 to 20 Plus Inc (OTCBB:TTTP) Fiscal Year End: Dec 31 52 Week High: $.25 Shares Outstanding : 30 Million Shares in the Public Float: 4 Million TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80 TARGET PRICE IN NEXT 10 DAYS: $0.92 The Company 12 to 20 Plus, Inc. (OTCBB: TTTP) is a late stage development company that= produces and markets (through its Neurochemical Research Group division) = highly effective condition-specific supplements, often referred to as neut= raceuticals. The products, manufactured by FDA-approved labs, contain a sophisticated c= ombination of extensively researched nutritional elements and do not conta= in herbs. Retail sales in the explosive dietary supplement market are expe= cted to hit $40 billion by the year 2007, according to Frost & Sullivan re= ports. Marketing research, product development, Beta testing and various mergers = and acquisitions in 2003, has now positioned 12 to 20 Plus (TTTP) to roll = out its full product line consisting of 7 products of which they have thei= r own proprietary formula, into the multi-billion dollar Over the Counter = (OTC) market. 12 To 20 Plus is ready to capitalize on its exceptional prod= uct line. Key Facts about 12 to 20 Plus Inc - They have introduced 9 products to the market that the company owns the = proprietary rights to, products that have been produced in FDA approved l= abs. - One of their products Anaplex (antidepressant) is currently being sold a= nd distributed in Longs Drug Stores, one of America=92s leading drug store= s with over 400 stores - The company is negotiating deals with two major distributors in Europe f= or their healthcare products. - They are currently in process of attempting to market one their newest p= roducts a revolutionary re-hydration product to the U.S Military and to al= lied forces overseas. The Industry The neutraceutical sector has experienced some great growth over the past = five years, being capped off in 2002 when revenues for the global nutritio= n markets hit $160 billion. United States took responsibility for about 1/= 3 of that, with $56.5 billion, 18.5 coming from the nutrition markets, $19= 8 from functional foods, and $4.4 billion from personal care products. It= =92s safe to say that globally we are looking for new ways to live healthi= er and longer lives, and that pharmaceutical remedies could quickly be a t= hing of the past. It=92s estimated that 95% of medical doctors` practices entail writing pha= rmaceutical prescriptions and that 50% of these prescriptions are to treat= the side effects of medications being utilized to treat the specific ailm= ent. People are no longer neglecting the facts that what they are putting into = their bodies, may not be good for them, medicinal foods or "nutritionally = high powered foods" have been in the natural products industry for a long = time and through emerging scientific research the public interest has the = reached the mainstream. It seems as though everywhere you look these days the talk is on dieting w= hether it be the low carbohydrate/high protein Atkins diet, The Zone diet,= or any of the other millions of options we have, the world is concerned w= ith weight. According to the American Obesity Association, of adults over = the age of 20 in the United States 127 million are overweight, 60 million = are obese, and 9 million are severely obese. Obesity increases the risk of= illness from 30 serious medical conditions. This fact is forcing many of = the snack food and soft drink companies to come up with new healthier prod= ucts that meet the taste standards of today=92s consumers. Comparable companies in this Sector - USANA Health Sciences Inc (Nasdaq:USNA) current price $27.39 - Nutraceutical International Corp (Nasdaq:NUTR) current price $25.97 - Vital Living Inc (OTCBB:VTLV) current price $.68 Disclaimer: This contains forward-looking statements within the meaning of The Private= Securities Litigation Reform Act of 1995. These statements may be identif= ied by such terms as expect", "believe", "may", "will", "explode","move","= undervalued" and "intend" or similar terms. The information in the above s= tatement could not be 100% accurate and the newsletter is not responsible = for this. We are NOT a registered investment advisor or a broker dealer. T= his is NOT an offer to buy or sell securities. No recommendation that the = securities of the companies profiled should be purchased, sold or held by = individuals or entities that learn of the profiled companies. This newslet= ter was paid $3000 in cash by third--party to publish this report.Investin= g in companies profiled is high-risk and use of this information is for re= ading purposes only. If anyone decides to act as an investor, then it will= be that investor's sole risk. Investors are advised NOT to invest without= the proper advertisement from an attorney or a registered financial broke= r. Do not rely solely on the information presented,do additional independe= nt research to form your own opinion and decision regarding investing in t= he profiled companies. Be advised that the purchase of such high-risk secu= rities may result in the loss of your entire investment. Void where prohib= ited. The owners of this publication or their partners may already own fre= e trading shares in TTTP and may immediately sell all or a the time this = date stated and are subject to change without notice. ----13230657194010274554--
next message in archive
no next message in thread
previous message in archive
Index of Subjects